Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C26H27ClN2 |
| Molecular Weight | 402.959 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)C(N2CCN(C\C=C\C3=CC=CC=C3)CC2)C4=CC=CC=C4
InChI
InChIKey=ZSQANMZWGKYDER-JXMROGBWSA-N
InChI=1S/C26H27ClN2/c27-25-15-13-24(14-16-25)26(23-11-5-2-6-12-23)29-20-18-28(19-21-29)17-7-10-22-8-3-1-4-9-22/h1-16,26H,17-21H2/b10-7+
| Molecular Formula | C26H27ClN2 |
| Molecular Weight | 402.959 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
Clocinizine is an antihistamine derivative of diphenylmethylpiperazine. Clocinizine is a competitive and reversible H1 receptor antagonist. The drug is marketed in Spain under tradename Senioral in combination with phenylpropanolamine for temporary relief of nasal congestion in colds, rhinitis, and sinusitis.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:52 GMT 2025
by
admin
on
Mon Mar 31 18:22:52 GMT 2025
|
| Record UNII |
8HQJ711KH8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C77435
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
8HQJ711KH8
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
SUB06685MIG
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104069
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
688
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
DTXSID601027146
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
Clocinizine
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
298-55-5
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
5375618
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
1599
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
m3632
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000084305
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | |||
|
402583
Created by
admin on Mon Mar 31 18:22:52 GMT 2025 , Edited by admin on Mon Mar 31 18:22:52 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
